Headwaters Signs Agrement for Coal Based Liquid Fuels Refinery in The Philippines

Headwaters Incorporated, announced today that its subsidiary has signed several agreements with H&WB Corporation in connection with a planned coal based liquid fuels refinery expected to use low rank coals from the Philippines.

Under these agreements Headwaters CTL, LLC will provide technology licenses, basic engineering design and technical services for the construction of a 60,000 BPD coal liquefaction facility in the Bataan Petrochemcial Industrial Zone. After design and construction, this integrated plant is intended to produce ultra clean liquid petrochemical feedstocks and transportation fuels such as LPG, gasoline, diesel and jet fuels. Preliminary front-end engineering study (pre-FEED), which includes pilot scale gasification and liquefaction tests of selected Philippine coals, is scheduled to start in May and will take approximately 18 months to complete. In addition, H&WB Corporation plans to evaluate coal supply logistics, conduct a market study for products, and assess options for carbon dioxide sequestration will be assessed.

It is anticipated that this hybrid CTL plant will be self sufficient for electric power and utilize an integrated design to take advantage of the two coal liquefaction approaches, direct and indirect, to produce 11,000 BPD of LPG, 27,200 BPD of gasoline and 22,900 BPD of diesel fuel from a projected coal feed of 11,700 short tons of coal per day.

“Headwaters is excited to sign its second coal liquefaction license agreement. Headwaters seeks to apply its experience to develop an efficient coal conversion facility fully utilizing the indigenous coal resources of the Philippines,” said, Ken Frailey, President of Headwaters Energy Services.

Headwaters has developed technology for processing low cost feedstocks like petroleum resid and coal. The company has proprietary catalysts for direct and indirect conversion of coal into ultra clean transportation fuels.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.